References
- Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like par-ticles in human sera. Lancet 1975;1:72–3.
- Serjeant GR, Topley JM, Mason K, Serjeant BE, Pattison JR, Jones SE, et al. Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus-like agent. Lancet 1981;2:595–7.
- Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauter-ine parvovirus infection associated with Hydrops fetalis. Lancet 1984;2:1033.
- Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, et al. Human parvovirus, the cause of Erythema infectiosum (fifth disease)? Lancet 1983;1:1378.
- Plummer FA, Hammond GW, Forward K, Sekla L, Thompson LM, Jones SE, et al. An Erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 1985;313:74–9.
- White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1:419–21.
- Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149:1153–6.
- Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;7:8227–32.
- Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Chin North Am 1998;24:375–401.
- Reid DM, Reid TM, Brown T, Rennie JA, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory descrip-tion. Lancet 1985;1:422–5.
- Moore TL, Bandlamudi R, Alam SM, Nesher G. Parvovirus infec-tion mimicking systemic lupus erythematosus in a pediatric popu-lation. Semin Arthritis Rheum 1999;28:314–8.
- Nesher G, Osborn TG, Moore TL. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995;24: 297–303.
- Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999;28: 319–25.
- Fawaz-Estrup F. Human parvovirus infection: rheumatic mani-festations, angioedema, Cl esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Ftheumatol 1996;23:1180–5.
- Tanaka A, Sugawara A, Sawai K, Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med 1998;37:708–10.
- Kalish RA, Knopf AN, Gary GW, Canoso JJ. Lupus-like presenta-tion of human parvovirus B19 infection. J Ftheumatol 1992;19:169–71.
- Sasaki T, Takahashi Y, Yoshinaga K, Sugamura K, Shiraishi T. An association between human parvovirus B-19 infection and auto-antibody production. J Ftheumatol 1989;16: 708–9.
- Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilym-phocyte antibodies during acute infection with human parvovirus B19. J Ftheumatol 1989;16: 777–81.
- Garcia-Tapia AM, Fernandez-Gutierrez del Alamo C, Giron JA, de la Rubia F, Martinez-Rodriguez A, Martin-Reina MV, et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain. Chin Infect Dis 1995;21: 1424–30.
- Gendi NST, Gibson K, Wordsworth BP. Effect of HLA and hypocomplementaemia on the expression of parvovirus arthritis: one year follow-up of an outbreak. Ann Rheum Dis 1996;55:63–5.
- Cope AP, Jones A, Brozovic M, Shafi MS, Maini RN. Possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis 1992;51:803–4.